Federal Register / Vol. 62, No. 26 / Friday, February 7, 1997 / Notices 5835

Operations, Office of Minority Health,

5515 Security Lane, Suite 1000,

Rockville, Maryland 20852, telephone

number (301) 594–0769.

The Catalog of Federal Domestic

Assistance number is 93.910.

Dated: January 13, 1997.

Clay E. Simpson, Jr.,

Deputy Assistant Secretary for Minority

Health.

[FR Doc. 97–3017 Filed 2–6–97; 8:45 am]

BILLING CODE 4160–17–M

Meeting of Commission on Dietary

Supplement Labels

AGENCY: Office of Disease Prevention

and Health Promotion.

ACTION: Commission on Dietary

Supplement Labels: Notice of meeting

#8.

SUMMARY: The Department of Health and

Human Services (HHS) is providing

notice of the eighth meeting of the

Commission on Dietary Supplement

Labels.

DATES: The Commission intends to hold

its meetings on March 4, 1997 from 1:00

p.m. to approximately 5:00 p.m., E.S.T.,

at the Omni Hotel, 101 West Fayette

Street, Baltimore, Maryland 21201. The

meeting is open to the public; seating is

limited.

FOR FURTHER INFORMATION CONTACT:

Kenneth D. Fisher, Ph.D., Executive

Director, Commission on Dietary

Supplement Labels, Office of Disease

Prevention and Health Promotion, Room

738G, Hubert H. Humphrey Building,

200 Independence Ave., SW.,

Washington, DC 20201, (202) 690–7102.

SUPPLEMENTARY INFORMATION: Public

Law 103–417, Section 12, authorized

the establishment of a Commission on

Dietary Supplement Labels whose seven

members have been appointed by the

President. The appointments to the

Commission by the President and the

establishment of the Commission by the

Secretary of Health and Human Services

reflect the commitment of the President

and the Secretary to the development of

a sound and consistent regulatory policy

on labeling of dietary supplements.

The Commission is charged with

conducting a study and providing

recommendations for regulation of label

claims and statements for dietary

supplements, including the use of

supplemental literature in connection

with their sale and, in addition,

procedures for evaluation of label

claims. The Commission is expected to

evaluate how best to provide truthful,

scientifically valid, and non-misleading

information to consumers in order that

they may make informed health care

choices for themselves and their

families. The Commission’s study report

may include recommendations on

legislation, if appropriate and necessary.

The Commission meeting agenda will

include approval of minutes of the

previous meeting, determination of the

appropriateness and possible date for

release of the Commission’s final draft

report for public review, review of

certain materials drafted for possible

inclusion in the Commission’s report,

and discussion of the process for review

of Commission’s final draft report. In

addition, the Commission has requested

further comments from several

organizations that previously provided

testimony and statements concerning (1)

regulatory management of herbal

remedies, and (2) possible use of third

parties for evaluation of dietary

supplement label claims. Oral

statements and the required written

statements of invited parties are to be

restricted to additional views, data, and

comments on these two topics. If time

permits after the statements of the

invited organizations, the Chair may

allow brief oral statements from other

interested parties and persons

concerning these two topics.

The meeting is open to the public;

however seating is limited. If you will

require a sign language interpreter,

please call Sandra Saunders (202) 690–

7102 by 4:30 p.m. E.S.T. on February 24,

1997.

Dated: January 30, 1997.

Linda D. Meyers,

Acting Deputy Director, Office of Disease

Prevention and Health Promotion,

Department of Health and Human Services.

[FR Doc. 97–3018 Filed 2–6–97; 8:45 am]

BILLING CODE 4160–17–M

National Institutes of Health

National Institute of General Medical

Sciences; Notice of Closed Meeting

Pursuant to Section 10(d) of the

Federal Advisory Committee Act, as

amended (5 U.S.C. Appendix 2), notice

is hereby given of the following

National Institute of General Medical

Sciences Special Emphasis Panel

meeting:

Name of Committee: Structural Biology of

AIDS Related Proteins.

Date: February 18, 1997.

Time: 1:00 p.m.—until conclusion

(approximately 3 hours).

Place: Natcher Building—Room 1 AS–13,

45 Center Drive, Bethesda, Maryland 20892–

6200 (Telephone Conference).

Contact Person: Arthur L. Zachary, Ph.D.,

Scientific Review Administrator, NIGMS,

Office of Scientific Review, 45 Center Drive,

Room 1AS–13, Bethesda, MD 20892–6200,

301–594–2886.

Purpose: To evaluate program project

proposals.

This notice is being published less than 15

days prior to the meeting due to the urgent

need to meet timing limitations imposed by

the review and funding cycle.

This meeting will be closed in accordance

with the provisions set forth in secs.

552b(c)(4) and 552b(c)(6), Title 5 U.S.C. The

discussions of these proposals could reveal

confidential trade secrets or commercial

property such as patentable material and

personal information concerning individuals

associated with the proposals, the disclosure

of which would constitute a clearly

unwarranted invasion of personal privacy.

(Catalog of Federal Domestic Assistance

Program Nos. 93.821, Biophysics and

Physiological Sciences; 93.859,

Pharmacological Sciences; 93.862, Genetics

Research; 93.863, Cellular and Molecular

Basis of Disease Research; 93.880, Minority

Access Research Careers [MARC]; and

93.375, Minority Biomedical Research

Support [MBRS])

Dated: January 31, 1997.

Paula N. Hayes,

Acting Committee Management Officer, NIH.

[FR Doc. 97–3077 Filed 2–6–97; 8:45 am]

BILLING CODE 4140–01–M

National Institute of General Medical

Sciences; Notice of Closed Meeting

Pursuant to Section 10(d) of the

Federal Advisory Committee Act, as

amended (5 U.S.C. Appendix 2), notice

is hereby given of the following

National Institute of General Medical

Science meeting:

Committee Name: Minority Program

Review Committee MARC, Minority Access

to Research Careers Sub-Committee.

Date: February 20–21, 1997.

Time: 8:30 a.m.—adjournment.

Place: Natcher Conference Center, 45

Center Drive—Conference Room C1/C2,

Bethesda, MD 20892–6200.

Contact Person: Richard I. Martinez, Ph.D.,

Scientific Review Administrator, NIGMS, 45

Center Drive, Room 1AS–19G, Bethesda, MD

20892–6200, 301–594–2849.

Purpose: To review institutional research

training grant applications.

This meeting will be closed in accordance

with the provisions set forth in secs.

552b(c)(4) and 552b(c)(6), Title 5, U.S.C. The

discussions of these applications could

reveal confidential trade secrets or

commercial property such as patentable

material and personal information

concerning individuals associated with the

applications, the disclosure of which would

constitute a clearly unwarranted invasion of

personal privacy.

(Catalog of Federal Domestic Assistance

Program Nos. 93.821, Biophysics and

Physiological Sciences; 93.859,

Pharmacological Sciences; 93.862, Genetics

Research; 93.863, Cellular and Molecular

Basis of Disease Research; 93.880, Minority